PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy.
Translational Lung Cancer Research
Fang, Wenfeng W; Huang, Yihua Y; Gu, Weiguang W; Gan, Jiadi J; Wang, Wenjing W; Zhang, Shiyue S; Wang, Kai K; Zhan, Jianhua J; Yang, Yunpeng Y; Huang, Yan Y; Zhao, Hongyun H; Zhang, Li L